Pages that link to "Q35907461"
Jump to navigation
Jump to search
The following pages link to Long-acting risperidone injection. (Q35907461):
Displaying 8 items.
- Long-acting atypical antipsychotics: characterization of the local tissue response (Q34130433) (← links)
- Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics (Q36830134) (← links)
- Risperidone long-acting injection in the treatment of schizophrenia spectrum illnesses: A retrospective chart review of 19 patients in the Vancouver Community Mental Health Organization (Vancouver, Canada) (Q37672702) (← links)
- Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review (Q38042430) (← links)
- Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection (Q38248274) (← links)
- Development of Risperidone PLGA Microspheres. (Q41962765) (← links)
- Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment (Q42639664) (← links)
- Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada (Q46896768) (← links)